SynBiotic is a stock listed platform company with a EU focused buy & build investment approach.
People are looking for solutions to their real-life problems. With cannabinoids we are able to address a multi-billion EU-market for sleep, pain and anxiety solutions with cumulative sales of over € 250 billion for OTC and pharmaceuticals in 2020.
over
people with sleep-related problems, such as disturbed sleep
over
people with chronic pain and similar issues
over
people with anxiety
SynBiotic’s organizational structure is built to cover all value drivers – from research over production to distribution
Beyond Cannabis for a multi-billion market. Regulations, market, and customer readiness make CBD the most promising cannabinoid to start with, building a solid foundation for our platform. But we focus not solely on CBD and THC, but also on other cannabinoids, endocannabinoids and terpenes with high potential.
Most CBX* have not been discovered yet, but studies show that other cannabinoids, beyond THC and CBD, have huge medical potential. In addition, the so called entourage effectis a term used to describe the synergistic effects of combining various chemical compounds found in cannabis. Most commonly, it refers to the interaction between THC/CBD and other cannabinoids or terpenes.
* CBX = all cannabinoids except THC
While CBD from hemp & cannabis plants is still a legal grey area, we focus in parallel on other plants that are rich in cannabinoids, endocannabinoids & terpenes.
Munich, April 6, 2021. The cannabis company SynBiotic SE is joining NeuroTheryX Canada Ltd (NeuroTheryX) and securing a complete takeover of its R&D platform by April1, 2023. With these decisions,
München, 6. April 2021. Das Cannabis-Unternehmen SynBiotic SE steigt bei NeuroTheryX Canada Ltd (NeuroTheryX) ein und sichert sich eine Komplettübernahme der R&D-Plattform bis zum 1. März 2023. Mit
Munich, March 9, 2021. For many years, consumers have been looking for alternatives to classic cow’s milk. Oat milk has become particularly popular here. Now,
SynBiotic SE – MAKING CANNABINOIDS ACCESSIBLE.
© 2021 Synbiotic SE | All rights reserved
Imprint Privacy policy
